About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Chewing Under Dual-Tasking in MS | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07366216

Chewing Under Dual-Tasking in MS

This study aims to investigate the effects of visual, auditory, and motor dual-task conditions on chewing performance in individuals with multiple sclerosis, compared with healthy controls.

Lead sponsor: Ondokuz Mayıs University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Seda Nur Kemer, PhD

CONTACT

+905467861866 sedakemer@gmail.com

Sponsors

Lead Sponsor

Ondokuz Mayıs University

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Individuals aged between 18 and 65 years
•Mini-Mental State Examination (MMSE) score of 24 or higher
•Right-hand dominance

Exclusion Criteria

•Presence of visual and/or hearing impairment
•Presence of difficulties in solid food intake and/or complaints related to mastication
•Presence of neurological, psychological, cognitive, and/or chronic conditions that may affect mastication or chewing function
•History of interventions affecting oral structure (e.g., oral/maxillofacial surgery or radiotherapy) within the last month
•Known allergy to the food used in the test

Related studies

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

RECRUITINGPhase 2

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490 · Multiple Sclerosis Spasticity

RECRUITINGPhase 3

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019 · Secondary Progressive Multiple Sclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment48

Start dateJan 2026

Last updatedJan 26, 2026

Condition

Multiple Sclerosis

Locations shown

Ondokuz Mayis University

Samsun

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions